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Streptococcus suis serotype 2 (SS2) is an emerging human pathogen worldwide. A
large outbreak occurred in the summer of 2005 in China. Serum samples from this
outbreak revealed that levels of the main proinflammatory cytokines were significantly
higher in patients with streptococcal toxic-shock-like syndrome (STSLS) than in patients
with meningitis only. However, the mechanism underlying the cytokine storm in STSLS
caused by SS2 remained unclear. In this study, we found that suilysin (SLY) is the
main protein inflammatory stimulus of SS2 and that native SLY (nSLY) stimulated
cytokines independently of its haemolytic ability. Interestingly, a small amount of SLY
(Å Mol/L) induced strong, long-term TNF-α release from human PBMCs. We also
found that nSLY stimulated TNF-α in wild-type macrophages but not in macrophages
from mice that carried a spontaneous mutation in TLR4 (P712H). We demonstrated
for the first time that SLY stimulates immune cells through TLR4. In addition, the
Myd88 adaptor-p38-MAPK pathway was involved in this process. The present study
suggested that the TLR4-dependent inflammatory responses induced by SLY in host
might contribute to the STSLS caused by SS2 and that p38-MAPK could be used as a
target to control the release of excess TNF-α induced by SS2.
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Introduction
The Gram-positive bacterium Strptococcus suis serotype 2 (SS2) can cause a systemic infection in
humans; sepsis and meningitis are the most common clinical manifestations (Tang et al., 2006;
Wangkaew et al., 2006; Huong et al., 2014). Severe sepsis can lead to streptococcal toxic-shock-like
syndrome (STSLS). In 2005, China reported more than 200 human cases with an unusual clinical
presentation of STSLS and a mortality rate of up to 20% (Sriskandan and Slater, 2006). Serum
samples revealed that TNF-α, IL-6,IL-1β, IL-8, IL-12p70 and IFN-γ were significantly higher in
patients with STSLS than in those with meningitis (Ye et al., 2009).
It was reported that cell walls and SLY can activate endothelial cells to release cytokines
(Vadeboncoeur et al., 2003). Stimulation of human monocytes with whole encapsulated S. suis or
purified cell wall components influences the expression of TLR2 and CD14mRNA (Graveline et al.,
2007). Recombinant SLY (rSLY) triggers the production of TNF-α by human monocytes and IL-
6 by pig PAMs and monocytes (Lun et al., 2003). SLY is a 497 amino-acid protein belonging to
the cholesterol-dependent cytolysin (CDC) family, which has more than 20 members, including
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perfringolysin O and streptolysin O, expressed by Clostridium
perfringens and Streptococcus pyogenes, respectively. Like other
members of the CDC family produced by Gram-positive bacteria,
a classical feature of these toxins is their ability to create
transmembrane pores in cholesterol-containing membranes
thereby causing cell lysis (Jacobs et al., 1994; Gottschalk et al.,
1995).
Sequence type 7 (ST-7) strains caused the human outbreak
in China in 2005 and were more toxic to human peripheral
blood mononuclear cells (PBMCs) than ST-1 strains (mainly
referring to the European virulent strains) (Ye et al., 2006).
Interestingly, the ST-7 strains produced more SLY than the
non-epidemic strains, and this contributed to invasive infection
(He et al., 2014). However, the mechanisms underlying the SLY
induced inflammatory responses of the host have not been fully
elucidated.
The pattern-recognition receptors (PRRs) in the host play
important roles in recognizing bacterial pathogens (Akira et al.,
2006). The PRRs, including Toll-like receptors (TLRs), RIG-I-
like receptors, NOD-like receptors and C-type lectin receptors,
recognize distinct microbial components to activate immune
cells (Takeuchi and Akira, 2010). TLRs are expressed in various
immune cells, including lymphocytes, monocytes and dendritic
cells (DCs) in blood and macrophages in tissue; and even
in non-immune cells, including fibroblasts, endothelial, and
epithelial cells. TLR4 usually was reported to recognizes the
lipopolysaccharides (LPS) from gram-negative bacteria (Akira
and Takeda, 2004; Kawai and Akira, 2006; Lu et al., 2008).
TLR4 can also confer responsiveness to the pneumolysin from
Streptococcus pneumoniae (Malley et al., 2003).
In this study, we eliminated the influence of LPS and
found that nSLY activates several types of immune cells
via TLR4, including human PBMCs from human blood,
primary peritoneal macrophages from mice, THP-1 and
RAW264.7 macrophages. Moreover, this inflammatory activity
is independent of its haemolytic ability. Interestingly, we also
found that the TLR4-MyD88-p38 MAPK signal transduction
pathway is essential for SLY-induced inflammatory cytokine
synthesis.
Materials and Methods
Reagents
Cell culture media, fetal bovine serum (FBS), penicillin G,
streptomycin, and β-mercaptoethanol were purchased from
GIBCO. Gel-filtration chromatography -purified Escherichia
coli O127:B8 LPS was purchased from Sigma. Antibodies (Abs)
for total and phospho-specific MAPKs were purchased from
Cell Signaling Technology. The MAPK inhibitors: SB203580
(p38) and SB202474 (the negative control for SB203580),
U0126 (ERK), and U0124 (the negative control for U0126) and
SP600125 (JNK) were purchased from Calbiochem. Polymyxin
B, CLI-095, Pepinh-Control, Pepinh-MYD, Pepinh-TRIF,
and Lipofectamine2000 were purchased from Invitrogen.
Dual Luciferse Reporter Assay Kits and Cyto Tox 96 Non-
Radioactive Cytotoxicity Assay Kits were purchased from
Promega.
Bacterial Strains
The virulent SS2 strain 05ZYH33 that belongs to sequence type
7 (ST-7) based on multilocus sequence typing, was originally
isolated from a STSLS patient in China in 2005 (Ye et al.,
2009). 1SLY, 1MRP, 1Fhb, 11083, and 11881 were the
isogenic mutants of sly, mrp, fhb, the ABC transporter 1083 and
HP1881 from 05ZYH33 (Pian et al., 2015), respectively, that were
constructed in our laboratory. The bacteria were grown overnight
on goat blood agar at 37◦C, and isolated colonies were inoculated
into Todd–Hewitt broth (THB, Difco).
Ethics Statement
The healthy donors who provided serum and plasma for this
study at the 307 Hospital provided written informed consent
in accordance with the Declaration of Helsinki. Approval
was obtained from the medical ethics committee of the 307
Hospital. This research was approved by the ethics committee
on Animal Experimentation of the Chinese Association for the
Accreditation of Laboratory Animal Care (CAALAC) and the
relevant local animal welfare bodies in China. In addition, the
permit number for all of the animal work was SCXK-(JUN)2013-
029), and this work was approved by the animal ethics committee
of the Beijing Institute of Microbiology and Epidemiology. All
efforts were made to minimize the suffering of the animals
employed in this study.
Real-time PCR Analysis
The gene expression of proinflammatory cytokines (IL-1β, IL-
6, and TNF-α) in hCMEC/D3 cells, induced by S. suis strains
(MOI = 10:1, stimulated for 2 h), was calculated as the mean
of the fold increase of in mRNA above that of the PBS group
as determined by real-time PCR analysis. Gene-specific primers
(Listed in Table S1) were designed to produce an amplicon of
100–150 bp for each cytokine gene tested. The contaminating
DNA in the samples was removed by using Amibion’s DNA-
free Kit (Applied Biosystems, Foster City, CA). cDNA was
generated by random hexamer primers, and real-time RT-PCR
was performed in triplicate using the Step One Plus system
together with the SYBR Green master mix. The relative mRNA
level were determined by calculating the threshold cycle (1Ct)
of each gene using the classic 1Ct method. Negative controls
were performed by using cDNA generated without reverse
transcriptase as templates. were also included as blank controls.
The β-actin gene was used as an internal control to normalize
all the other genes. The samples from at least three independent
experiments were analyzed.
The Inflammatory Activity Induced by SLY In Vivo
Six-weeks-old female ICR mice were randomly divided into
three groups with six mice per group. The three groups of
mice were challenged intraperitoneally (i.p.) with 0.3ml (∼5 ×
108 CFU/ml) of stationary-phase WT 05ZYH33, the sly mutant
1SLY or THB. At certain times post-infection (4, 8, and 12
h), mice in each group were euthanized. The sera isolated
from the blood were used to determine IL-1β, IL-6, TNF-
α, and IL-10 levels with the Mouse Cytokine 10-Plex Panel
(Merck).
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Purification of SLY Protein and Removal of
Endotoxins
The purification and characterization of native SLY (nSLY) were
performed as previous report (Jacobs et al., 1994; Lv et al., 2011).
Recombinant expressed SLY (rSLY) and the SLYP353V mutant
proteins used in this study were previously reported (Ren et al.,
2012). Endotoxins were removed with Triton X-114 (Liu et al.,
1997). The remaining endotoxin contamination in proteins, cell
culture medium and solutions contained less than 0.03 EU/ml, a
concentration below that which is known to cause cell activation
(Martin and Dorf, 1991).
Titration of Haemolytic Activity
The nSLY, rSLY, and SLYP353V proteins were evaluated via
titration of their haemolytic activity as in our previous study (Hao
et al., 2013). Briefly, serial two-fold dilutions of the proteins were
prepared in polystyrene deep-well titer plates with PBS (with
or without 0.1% β-mercaptoethanol). Subsequently, an equal
amount of human red blood cells (RBC) (final concentration of
RBS: 2%) was added to each well. Following incubation for 1 h
at 37◦C, the mixtures were centrifuged (1500 g for 10min), the
supernatants were transferred to polystyrene microplates, and
their absorbance was measured at 540 nm with a microELISA
reader. Triton X-100 was used as the positive control. Haemolytic
units (HU) were calculated from the endpoint (defined as 50%
lysis). The endpoint was estimated as the well in which the
erythrocyte pellet was half the size of those in control wells
without added proteins.
Cell Lines and Isolation of Primary Cells
THP-1 cells, a monocytic cell line that treated with PMA
(50 ng/ml) for 48 h to induce macrophage differentiation.
RAW264.7, a macrophage cell line, were maintained in
RPMI 1640 supplemented with 10% (v/v) FBS. Human
embryonic kidney 293T cells (HEK) were maintained in
DMEM supplemented with 10% (v/v) FBS. The hCMEC/D3,
an immortalized human cerebral microvascular endothelial cell
line, was maintained in EBM-2 basal medium with fetal bovine
serum (5%), penicillin-streptomycin (1%), hydrocortisone
(1.4µM), ascorbic acid (5µg/ml), chemically defined lipid
concentrate (1/100), HEPES (10mM) and bFGF (1 ng/ml).
Primary peritoneal macrophages were isolated from mice as
described (Malley et al., 2003). Human PBMCs were prepared
from fresh heparinized blood from healthy volunteers. The
blood was diluted 1/1 in PBS and layered on top of Ficoll-Paque
Plus (Amersham Biosciences). After centrifugation at 1000 g
FIGURE 1 | SLY is the main protein in S. suis that stimulates
inflammation. (Ai-iii) The gene expression of proinflammtory cytokines
(IL-1β, IL-6 and TNF-α) in hCMEC/D3 cells induced by S. suis strains
(MOI = 10:1, stimulated for 2 h). Data are expressed as the mean ±
SD of the fold increase of mRNA above the PBS group for at least
three independent experiments. (Aiv) The release of interleukin-6 (IL-6)
by hCMEC/D3 was detected after stimulation with a live S. suis strain
05ZYH33 or its 1SLY mutant (MOI = 10:1) for 3 h. Data are expressed
as mean ± SD for at least three experiments and are analyzed by
Student’s unpaired t-test. (B) The levels of cytokines in ICR mouse
serum after i.p. infection with 0.3ml of live S. suis culture liquid (108
CFU/ml). Each symbol represents the serum cytokine levels (pg/ml) in
one mouse. Horizontal lines indicate the median for each group, and
the data were analyzed by the Mann-Whitney test. n.s. no significance.
*P < 0.05; **P < 0.01; ***P < 0.001. n.s. no significance; 1SLY, an
isogenic mutant of sly from 05ZYH33; THB, Todd-Hewitt broth.
Frontiers in Microbiology | www.frontiersin.org 3 June 2015 | Volume 6 | Article 644
Bi et al. TLR4 and suilysin
for 20min at room temperature, the PBMC layer was collected
and washed twice in medium. All cell culture experiments were
conducted under sterile conditions, and cells were cultured at
37◦C in a 5% CO2 atmosphere.
The Cytotoxicity of nSLY to Immune Cells
The immune cells (PBMCs, primary peritoneal macrophages
from mice, THP-1 and RAW264.7 macrophages) were added at
a density of 1 × 106 cells/ml into 96-well culture plates. The
nSLY was added to the cell culture wells to a concentration of
100 ng/ml. The cytotoxicity of nSLY to immune cells was detected
with Cyto Tox 96 Non-Radioactive Cytotoxicity Assay Kits after
4 h of incubation.
Cytokine Detection by Enzyme-linked
Immunosorbent Assay (ELISA)
PBMCs, THP-1 macrophages, RAW264.7 macrophages and
primary macrophages from mice (1× 106 cells/ml in RPMI 1640
supplemented with 10% FBS) were stimulated with protein or
LPS for 16 h at 37◦C in a 5% CO2-95% air incubator. Cells were
pelleted by centrifugation, and the cytokine concentrations in
the supernatants were determined by ELISA according to the
manufacturer’s protocol (R&D Systems).
Western Blotting
Proteins were separated on SDS-polyacrylamide gels and then
transferred to polyvinylidene difluoride (PVDF) membranes.
The membranes were blocked with 5% (w/v) BSA for 1 h
at room temperature and then incubated overnight at 4◦C
with primary antibodies in TBST (0.1%, v/v) with 1% (w/v)
BSA. After washing, the membranes were incubated with HRP-
conjugated secondary antibodies (Cell Signaling Technology) for
1 h at room temperature, followed by development with a BM
chemiluminescence reagent (Roche).
NF-κB Luciferase Reporter Gene Assays
HEK293T and RAW264.7 cells were transiently transfected with
Lipofectamine 2000 transfection reagent (Invitrogen) according
FIGURE 2 | SLY induces strong, long-term TNF-α release from human
PBMCs. (A) Heated, inactivated nSLY could not induce TNF-α release from
PBMCs. The nSLY was heated at 100◦C for 30min and then incubated with
PBMCs at a concentration of 100 ng/ml. Culture supernatants were
harvested and assayed for TNF-α production by ELISA. Each symbol
represents the level of TNF-α (pg/ml) released from the PBMCs from one
donor in one independent experiment. Horizontal lines indicate the mean for
each group, and the data in were analyzed by Student’s unpaired t-test.
Dose (B) and time-course (C) of production of TNF-α in PBMCs from
different donors treated with nSLY (100 ng/ml). Dose response (D) of TNF-α
production in THP-1 macrophage cells treated with nSLY or LPS. Culture
supernatants were harvested and assayed for cytokine production by ELISA.
Data are expressed as the mean ± SD for three independent experiments.
nSLY, native SLY; nSLY-heat, the native SLY was heated at 100◦C for 30min.
*P < 0.05; **P < 0.01; ***P < 0.001. The comparisons between test groups
and the control in (D) were analyzed by a One-Way ANOVA test.
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to the manufacturer’s instructions. After 24 h, the cells were
stimulated with LPS (100 ng/ml) or SLY (100–800 ng/ml) for 6 h
before lysis.
Statistical Analysis
ELISA results are expressed as the mean ± SD of the pg/ml
values. Differences between two groups were analyzed using
the unpaired two-tailed Student’s t-test; if Levene’s test was not
significant (P > 0.05), a Mann-Whitney tests were used. A One-
Way analysis of variance (ANOVA) was used to compare the
means of three or more samples. For all tests, a value of P < 0.05
was considered as the threshold for significance. All statistical
analyses were carried out using SPSS 15.0 (SPSS Inc., Chicago,
IL, USA).
Results
SLY is the Main S. suis Protein That Stimulates
Inflammation
To identify the inflammatory stimulus of S. suis, several genes
encoding potential virulence factors, including SLY (12), MRP
FIGURE 3 | The inflammatory activity of nSLY is independent of its
haemolytic activity. (A) The haemolytic activities of nSLY, rSLY, and
SLYP353V were tested. One haemolytic unit is defined as the reciprocal of
the SLY titre, which was calculated as the highest dilution of the protein
that caused at least 50% haemolysis. The data are expressed as the
mean ± SD for three independent experiments. (B,C) The nSLY
induced-TNF-αrelease is independent of its haemolytic activity. (B) PBMCs
were isolated from healthy volunteers and incubated with nSLY
(100 ng/ml) pretreated with 0.1% β-ME or with nSLY (100 ng/ml; no
pretreatment), LPS (100 ng/ml) was used as a positive control. The
concentration of TNF-α was measured by ELISA. Each symbol represents
the level of TNF-α (pg/ml) released from the PBMC from one donor in
one independent experiment. Horizontal lines indicate the median for
each group, and the data were analyzed by the Mann-Whitney test. n.s.
no significance. (C) PBMCs were isolated from healthy volunteers and
incubated with nSLY (100 ng/ml) pretreated with cholesterol (1.5µg/ml) or
with nSLY (100 ng/ml; no pretreatment), LPS (100 ng/ml) was used as a
positive control. The concentration of TNF-α was measured by ELISA.
Each symbol represents the level of TNF-α (pg/ml) released from the
PBMC from one donor in one independent experiment. Horizontal lines
indicate the median for each group, and the data were analyzed by the
Mann-Whitney test. n.s. no significance. (D) The rSLY induced
TNF-αrelease is affected by its haemolytic activity. PBMCs were incubated
with SLYP353V (3.125–25µg/ml), rSLY (3.125–25µg/ml) or an irrelevant
protein (25µg/ml) for 16 h. The concentration of TNF-α was measured by
ELISA. The rSLY, SLYP353V and irrelevant protein (IRR) were purified by
the same procedure. Each symbol represents the levels of TNF-α (pg/ml)
released from the PBMC from one donor in one independent experiment.
Horizontal lines indicate the median for each group, and the data were
analyzed by the Mann-Whitney test. **P < 0.01.
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(Vecht et al., 1996; Yang et al., 2006; Rehm et al., 2007), Fhb
(Pian et al., 2012), HP1083 and HP1881 were knocked out
in our laboratory, and then the mutant and WT strains were
compared for their inflammatory capacities. Surprisingly, in
hCMEC/D3 cells, only 1SLY exhibited a significant decrease
in its capacity to induce the transcription of proinflammatory
cytokines (TNF-α, IL-6, IL-1β, and IL-8) compared with the
WT strain (Figure 1A and Figure S1). The obvious loss of
IL-6 release from hCMEC/D3 induced by 1SLY, compared
to the WT, was verified by ELISA (Figure 1B). To evaluate
the roles of SLY-induced inflammation in vivo, 4-week-old
SPF ICR mice (six mice/group) were challenged i.p. with WT
05ZYH33 and the mutant 1SLY; and then the serum levels of
cytokines were analyzed at different times. The serum levels of
the proinflammatory cytokines (TNF-α, IL-6 and IL-1β) were
significantly higher in mice infected with WT 05ZYH33 than in
those infected with 1SLY at specific time point (Figure 1Bi–iii).
However, low levels of the anti-inflammatory cytokine IL-10 were
detected with no difference between the WT and the mutant
1SLY (Figure 1Biv). These results indicated that SLY was an
important inflammatory stimulus of S. suis.
SLY is a Strong Inflammatory Activator of PBMCs
Unlike most other cytokines, TNF-α administered in vivo
produces dramatic physiological changes and large doses of TNF-
α can result in tissue damage and metabolic changes that clearly
mimic endotoxic shock (Tracey et al., 1987; Hesse et al., 1988;
Whicher and Evans, 1990). TNF-α was chosen as the main
marker of inflammatory activity in the present study.We purified
the nSLY from the supernatant of a bacterial culture as in our
FIGURE 4 | TLR4 on immune cells mediated the inflammatory activity
of SLY. PBMCs (A), THP-1 macrophages (B) or primary peritoneal
macrophage isolated from C57BL/6 mice. (C) were pre-incubated with
CLI-095 (6.4µM) for 6 h, and then nSLY (100 ng/mL) or LPS (100 ng/ml) was
added for another incubation for 16 h. In (A–C), the culture supernatant were
harvested and assayed for cytokine production by ELISA. Each symbol in (A)
represents the level of TNF-α (pg/ml) released from PBMC from one donor in
one independent experiment. Horizontal lines indicate the median for each
group, and the data were analyzed by the Mann-Whitney test. (D) Primary
peritoneal macrophages isolated from C3H/HeN (black) or C3H/HeJ (white)
mice were incubated with LPS (100 ng/mL) or nSLY (100 ng/mL) for 16 h.
Concentrations of TNF-α in sera from mice were measured by ELISA. The
data in (B–D) are expressed as the mean ± SD for three independent
experiments. The data were analyzed by Student’s unpaired t-test. *P < 0.05;
***P < 0.001; n.s., no significance; C3H/HeN, the WT mice; C3H/HeJ, the
mice carry a missense point mutation in the TLR4 gene (P712H).
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previous study (Ren et al., 2012) and detected its ability to
induce the TNF-α release from immune cells. To exclude the
possibility that the observed inflammatory activity of nSLY is
attributable to contaminating LPS or other endotoxins, removal
of endotoxin from the proteins was carried out. Subsequently,
the final endotoxin contamination for nSLY, rSLY, and SLYP353V
used in this study is less than 0.03 EU/ml, a concentration below
that which is known to cause cell activation (Martin and Dorf,
1991). Moreover, we used heat to abolish the activity of nSLY to
induce TNF-α release from PBMCs. As shown in Figure 2A, the
inflammatory response was lost when nSLY was heated (at 100◦C
for 30min), indicating that this activity of nSLY was due to the
protein, not to endotoxin contamination.
We also found that nSLY induces TNF-α release from PBMCs
(Figure 2B), THP-1 macrophages (Figure 2D), RAW264.7 cells
(Figure 6C) and primary peritoneal macrophages from C57BL/6
(Figure 4C) and C3H/HeN mice (Figure 4D). A strong activator
of PBMC, 100 ng/ml nSLY induced the higher TNF-α release
from PBMCs than from other macrophages (Figures 2B,D,
4C,D, 6C). Then we performed serial concentrations of
nSLY with different incubation times with the PBMCs.
Interestingly, as shown in Figure 2B, PBMCs were more
sensitive and demonstrated a stronger response to SLY than
THP-1 macrophages (Figures 2B,D). Furthermore, unlike the
mouse infection model (Figure 1B), SLY produced long-term
stimulation of TNF-α release from PBMCs isolated from human
blood (Figure 2C). Therefore, in vitro assays with cells following
nSLY stimulation for 16 h were performed.
The Inflammatory Activity of nSLY is Independent
of Its Haemolytic Activity
Cellular necrosis or cleavage can induce inflammatory reactions;
therefore, the inflammatory activity of SLY could depend on
its haemolytic activity. Members of the CDC family share
similar functions: they bind to the target cell membrane via
interactions with specific receptors, including cholesterol and
CD59 (Giddings et al., 2004; Xu et al., 2010). Cholesterol can
obviously inhibit their haemolytic ability. To determine whether
the role of SLY in stimulating cytokines production requires
its haemolytic activity, we purified recombinant expressed
SLY (rSLY) and the SLY variant containing a point mutation
(SLYP353V) which lost all hemolytic activity (Ren et al., 2012).
We found that nSLY without β-ME had less haemolytic activity
(5079U/mg) than nSLY supplemented with β-ME (81267U/mg).
rSLY had even less haemolytic activity (1026U/mg), and
SLYP353V lost all haemolytic activity (Figure 3A), indicating that
the purified nSLY and rSLY lost most of their haemolytic activity
without β-ME to reduce the disulphide bond. The concentration
of 100 ng/ml (without haemolytic activity and cytotoxicity to
PBMCs, data not shown) of nSLY is sufficient to induce a
strong response in PBMCs and the release of TNF-α (Figure 3B).
Additionally, β-ME had a limited effect on nSLY-induced TNF-
α release (Figure 3B). Moreover, we found that cholesterol
had no effect on the inflammatory ability of nSLY in PBMCs
(Figure 3C and Figure S2). Although SLYP353V induced less
TNF-α release than rSLY at the same concentration in PBMCs,
SLYP353V preserved its inflammatory activity (Figure 3D). These
results confirmed that the inflammatory activity of nSLY
is different from that of rSLY, and that it is independent
of its haemolytic activity, suggesting that the inflammatory
activity of nSLY might depend on a specific host receptor, but
not on cellular necrosis or cleavage due to the cytotoxicity
of SLY.
The Inflammatory Activity of SLY Occurs in a
TLR4-dependent Manner
Pneumolysin (PLY) of S. pneumoniae, induces a TLR4-dependent
proinflammatory response in macrophages (Malley et al., 2003).
FIGURE 5 | SLY-activated immune cells produce TNF-α primarily
through the MyD88 adaptor. PBMCs (A) or RAW264.7 (B) were
pretreated with 10µM of pepinh-control (con), pepinh-MYD (MYD), or
pepinh-TRIF (TRIF) for 6 h and then they were incubated with LPS
(100 ng/ml) or SLY (100 ng/ml) for 16 h. The concentrations of TNF-α
were measured in the supernatants by ELISA. Each symbol in (A)
represents the level of TNF-α (pg/ml) released from PBMCs from one
donor in one independent experiment. Horizontal lines indicate the
median for each group, and the data were analyzed by the
Mann-Whitney test. The data in (B) are expressed as the mean ±
SD for three independent experiments. The data were analyzed by
Student’s unpaired t-test. *P < 0.05; **P < 0.01; n.s., no significance;
Con, pepinh-control; pepinh-MYD, the inhibitor of MyD88; pepinh-TRIF,
the inhibitor of TRIF.
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The mechanisms underlying SLY induced inflammation was
studied in this study. First, we used CLI-095, a specific inhibitor
of TLR4 (Ii et al., 2006; Kawamoto et al., 2008) and found that it
blocked the SLY-induced cytokine release in PBMCs (Figure 4A),
THP-1M8 cells (Figure 4B) and peritoneal macrophages from
C57BL/6 mice (Figure 4C). Second, we compared TLR4
dependent SLY inflammatory activity in macrophages isolated
from wild-type mice (C3H/HeN) with activity in macrophages
isolated from TLR4 point-mutant mice (C3H/HeJ). C3H/HeJ
mice carry amissensemutation in the TLR4 gene (P712H), which
renders them hypo-responsive to LPS (Poltorak et al., 1998). As
shown in Figure 4D, SLY activates the synthesis of TNF-α in
peritoneal-derived macrophages from WT mice but could not
activate mutant peritoneal-derived macrophages, demonstrating
that SLY induces inflammatory cytokine production through
TLR4 on immune cells.
MyD88 is the Main Adaptor Protein in the
SLY-TLR4 Signaling Pathway
TLR4 triggers MyD88-dependent and TRIF-dependent signaling
(Lu et al., 2008). MyD88 is required for full signaling in
the TLR pathway. To discriminate MyD88- or TRIF-mediated
signaling downstream of SLY-TLR4, we used MyD88 and TRIF-
specific inhibitors (pepinh-MYD and pepinh-TRIF, respectively)
and pepinh-Control in this study. Pepinh-MYD inhibited SLY-
induced TNF-α release in PBMCs (Figure 5A) and RAW264.7
(Figure 5B). However, pepinh-TRIF played only a limited role
for PBMCs and RAW264.7 (with no significant effects compared
FIGURE 6 | MAPK is involved in SLY-induced TNF-α release by
immune cells. PBMCs (A), THP-1 macrophages (B) or RAW264.7
macrophages (C) were pretreated with 10µM of SB203680,SB202474,
U0126, U0124, or SP600125 for 1 h, and then they were incubated with LPS
(100 ng/ml) or SLY (100 ng/ml) for 16 h. Culture supernatants were harvested
and assayed for cytokine production by ELISA. Each symbol in (A)
represents the level of TNF-α (pg/ml) released from PBMCs from one donor
in one independent experiment. Horizontal lines indicate the mean for each
group. Data in (B,C) are expressed as the mean ± SD for three independent
experiments. All data were analyzed by Student’s unpaired t-test. **P < 0.01;
***P < 0.001; n.s., no significance. MAPK inhibitor, SB203580 (p38), and
SB202474 (the negative control for SB203580), U0126 (ERK), and U0124
(the negative control for U0126), SP600125 (JNK). (D) The p38-MAPK
phosphorylation induced by nSLY. PBMCs were incubated with nSLY
(100 ng/ml) for different times (min) and then lysed for SDS-PAGE and
Western blot. The total/phosphorylated p38 was detected by Abs against
human total/phospho-specific p38 and HRP-conjugated secondary
antibodies.
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with the pepinh-Control treatment), indicating that MyD88 is
the main downstream adaptor of TLR4 in SLY-induced TNF-α
synthesis (Figure 5B).
Involvement of MAPK in TNF-α Release by
Immune Cells Stimulated with SLY
Mitogen-activated protein kinase (MAPK) is an important
serine/threonine protein kinase in inflammatory development.
Four MAPK pathways are activated upon LPS-TLR4 stimulation
in macrophages, including ERK, JNK/SAPK, p38, and
BMK/ERK5. We analyzed whether these MAPKs are involved
in SLY induced inflammatory response. We used inhibitors of
p38 (SB203580), ERK (U0126) and JNK (SP600125) and found
that SB203580 had a powerful effect on PBMCs (Figure 6A), but
limited effect on RAW264.7 (Figure 6C) and it had no effect on
THP-1 macrophages (Figure 6B). In contrast, U0126 inhibited
inflammatory activity in all cell types tested (Figures 6A–C),
but SP600125 had no effect on these cell types. MAPK may
play a co-operative role in TNF-α synthesis when SLY activates
immune cells. We then used western blotting to evaluate the
activation of MAPKs. ERK-MAPK phosphorylation was not
detected in PBMCs and RAW264.7 (data not shown). As shown
in Figure 6D, nSLY induced p38-MAPK phosphorylation in
PBMCs within 2 h, indicating that SLY can activate p38-MAPK
in PBMCs.
Native SLY Activates NF-κB
NF-κB (p50/p65) and AP-1 (c-Fos/c-Jun) are the important
transcription factors of the TLR4-MAPK signal pathways
activated by LPS, and they coordinate the induction of many
genes encoding inflammatory mediators (Guha and Mackman,
2001). SLY induced TNF-α release from macrophages via TLR4
(Figures 4B–D). Therefore, the association of NF-κB and AP-1
activation with SLY-induced inflammation was evaluated in our
FIGURE 7 | Native SLY can activate NF-κB in RAW264.7. RAW264.7 cells
were transiently transfected with SV40-luciferase and NF-κB renilla-luciferase.
Twelve hours after transfection, the cells were stimulated with LPS (100 ng/mL)
or SLY (100–800 ng/mL) for 12 h. The cells were lysed, and the luciferase and
renilla-luciferase acitivities were measured. Results were normalized for
renilla-luciferase activity and represented as fold stimulation over the
non-stimulated controls. The results are expressed as the mean ± SD for three
experiments, and a One-Way ANOVA test was used for statistical analysis.
*P < 0.05; **P < 0.01.
study. Luciferase reporter experiments were performed to study
the role of SLY in activating the NF-κB transcription factor. As
shown in Figure 7, nSLY, similar to the positive control LPS,
activated NF-κB in RAW264.7 cells; however, it did not activate
AP-1 (data not shown). These results suggested that NF-κBmight
be involved in SLY-induced inflammatory activity.
Discussion
The streptococcal toxic shock like syndrome (STSLS) in the large
S. suis outbreak in 2005 in China caused a high incidence of
morbidity and mortality despite antibiotic therapy (Sriskandan
and Slater, 2006). The ST-7 strains that caused this outbreak
have been reported to induce higher level of cytokine release in
experimentally infected mice than ST-1 and ST-25. Moreover,
serum samples from the 2005 outbreak revealed cytokine levels
that were significantly higher in patients with STSLS than in
patients with meningitis only. Researchers believe that ST7 has
the ability to stimulate the production of massive amounts of
proinflammatory cytokines, leading to STSLS (Ye et al., 2009).
Although some components of S. suis, including CPS, cell
walls, and SLY have been reported to be inflammatory activators
FIGURE 8 | Schematic of the cell signal pathway involved in the
SLY-induced inflammatory response in PBMCs. The
TLR4-MyD88-p38MAPK signal transduction pathway in the SLY-induced
inflammatory response in PBMCs is shown. The main effective inhibitors of this
signal pathway are marked in red.
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of endothelial cells (Vadeboncoeur et al., 2003) or immune
cells (Lun et al., 2003; Graveline et al., 2007), the specific
contributions of SLY to host inflammatory responses remain
unclear. In this study, by comparing the inflammatory activity
of WT S. suis and its isogenic sly mutant, we found that SLY is
an important contributor to these responses. Interestingly, the
ST-7 strain showed higher levels of SLY than the non-epidemic
strains in our previous study (He et al., 2014) or in a study by
another investigator (Ye et al., 2006). Therefore, the mechanisms
underlying SLY induced inflammatory responses in hosts were
studied. The results will possibly lead to effective rules to control
inflammation and STSLS caused by S. suis.
In some studies, the concentrations of stimuli that induced
inflammation were very high (purified CPS at 100µg/ml and
purified cell walls at 150µg/ml), and the release of TNF-α
(Graveline et al., 2007; Tanabe et al., 2010) was lower than in
our study. In our study, a small amount of SLY (Å Mol/L)
induced strong, long-term TNF-α release from human PBMCs
(Figures 2B,C). The bacteria can easily be obtained from patient
blood samples in China (Huong et al., 2014), and it is very
dangerous when the bacteria enters the blood because Å mol/L
of SLY can activate human PBMCs, resulting in the release large
amounts of TNF-α throughout the body. We therefore used
human PBMCs as an important immune cell type for study. Our
results indicated that human PBMCs are more sensitive to SLY
than THP-1 macrophages, RAW264.7 and primary peritoneal
macrophages from mice. Further research should focus on how
SLY interacts with human PBMCs. We demonstrated for the
first time that SLY activates human PBMCs via TLR4. Moreover,
SB203580, a p38-specific inhibitor, can completely inhibit TNF-α
release from PBMCs, but not from THP-1. This means that p38
is a possible target to control TNF-α release induced by S. suis
in host blood and that the specific inhibitors of p38 are potential
therapeutic drugs. Host inflammation is a double-edged sword
during host-pathogen interactions. It can help the host clear
bacteria but can cause damage to the host when the inflammation
is uncontrolled.
We found that the inflammatory activity of nSLY for PBMCs
is not due to its haemolytic activity. The rSLYP353V protein has
less inflammatory activity than rSLY, but it demonstrates some
activity with increasing stimulatory concentrations. This result
was in contrast to the recent report that a vaccine candidate,
the rSLYP353L mutant, induces significantly less proinflammatory
response than its wild-type counterpart (Du et al., 2013). This
discrepancy might be due to the different models used in our
study and the previous report. Although 60µg of SLY and
rSLYP353L was used in a mouse model in that report, it is not clear
that this amount of SLY is released during in the real infection
process.
We conclude that TLR4 mediates innate immune responses
to SLY, a CDC, independent of its cytolytic activity. SLY appears
sensitive and powerful to human PBMCs. Given these results,
we suggest that STSLS may be due to the robust inflammatory
response to S. suis. This response is mediated by a TLR4-MyD88-
p38 MAPK signal transduction pathway. In blood, SLY may be
the main stimulus of the cytokine storm. Based on our results, the
main effective inhibitor of the TLR4-MyD88-p38 MAPK signal
transduction pathway in the SLY-induced inflammatory cytokine
release is shown in Figure 8. From this, it may be possible to
provide rules to treat STSLS caused by S. suis 2.
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Figure S1 | SLY is the main S. suis protein that stimulates of inflammation.
The gene expression of proinflammatory cytokines (IL-6, IL-8) in hCMEC/D3 cells
induced by S. suis WT and the mutant strains (MOI = 10:1, stimulated for 2 h).
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Figure S2 | The haemolytic activity of nSLY and the inhibiting effect of
cholesterol. The 2% erythrocytes were incubated with nSLY (10µg/ml)
pretreated with 0.1% β-ME or with nSLY (10µg/ml) pretreated with 0.1% β-ME
and cholesterol (1.5µg/ml).
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